BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
Front Page 
UK Politics 
Background Briefings 
Medical notes 
Talking Point 
In Depth 

Wednesday, 27 June, 2001, 11:27 GMT 12:27 UK
Hopes for diabetes cure
Diabetes pen and needle
The treatment offers a permanent cure for diabetes type 1
A simple 40-day treatment that cures type 1 diabetes in mice could offer hope for a permanent cure for humans.

American researchers said that the laboratory tests had shown that the effects of the disease could be reversed.

But scientists said they need more cash to get the drug into clinical trials.

About 1 million Americans have type 1 diabetes, also known as juvenile diabetes because it is often diagnosed in children.

It's really a permanent reversal of an established autoimmune disease

Dr Denise Faustman

Cells destroyed

In type 1 diabetes, the body does not produce insulin, which is needed to convert sugar into fuel and is normally produced in the pancreas in cells called islet cells.

In people with type 1 diabetes, the islet cells are destroyed by the body's own misguided immune cells and sugar builds up dangerously in the blood.

Research, reported in the Journal of Clinical Investigation, showed it was possible to treat the mice for just 40 days and to re-train their immune systems so that they did not mistakenly attack the islet cells.

First, the researchers triggered a naturally occurring drug called TNF-alpha that killed the rogue immune cells.

Then they injected the mice with donor cells that re-educated their immune systems so that they would accept islet cells and not destroy them.

The insulin-producing cells appeared to re-grow in the diseased mice, providing enough so that their blood sugar came back to normal.

Study author Dr Denise Faustman, of Massachusetts, General Hospital said that up to 75% of the mice stayed healthy for 100 days or more, without any further treatment.

She said: "It's really a permanent reversal of an established autoimmune disease, and if that's not as good as it gets, the next thing that happens is the islets regenerate in the pancreas."


But Dr Faustman said the trials were being hampered by a lack of cash.

"If we had money to produce the drug and do the treatment, we'd be in clinical trials within a year."

Dr David Nathan, director of the diabetes centre at Massachusetts General Hospital, was cautiously optimistic.

He said: "This represents a very new discovery in an animal model of type 1 diabetes that has always been used to predict what happens in human diabetes.

"However until we explore more thoroughly whether the same phenomenon that occurs in mice occurs in human diabetes, we have to be cautious about the potential meaning of these findings ... whether this may represent the first insight in how to cure type 1 diabetes."

Mairi Benson, of Diabetes UK, said: "The research results arising from the work carried out at Massachusetts General Hospital are extremely interesting.

"There is still much to be understood, however, about the autoimmune process in human diabetes mellitus and Diabetes UK looks forward to seeing the results of this study being taken forward from work on mice to humans."

Search BBC News Online

Advanced search options
Launch console
See also:

17 Jun 01 | Health
'An end to insulin jabs'
10 Jun 01 | Health
Diabetes deaths 'unnecessary'
19 Apr 01 | Health
'Bad teeth' link to diabetes
02 Feb 01 | Health
Inhalers for diabetics
Internet links:

The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.

E-mail this story to a friend

Links to more Health stories